Loading clinical trials...
Loading clinical trials...
The Icosapent Ethyl and Prevention of Vascular Regenerative Cell Exhaustion Study
Conditions
Interventions
Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
Locations
3
Canada
The Oshawa Clinic
Oshawa, Ontario, Canada
Diagnostic Assessment Centre
Scarborough Village, Ontario, Canada
Langstaff Medical Clinic
Vaughan, Ontario, Canada
Start Date
September 24, 2020
Primary Completion Date
May 25, 2023
Completion Date
May 25, 2023
Last Updated
April 2, 2024
NCT06909773
NCT06505109
NCT06189313
NCT06706206
NCT05641662
NCT06931470
Lead Sponsor
Canadian Medical and Surgical Knowledge Translation Research Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions